Affiliation:
1. Ottawa Hospital, Ottawa Hospital Research Institute, and University of Ottawa, Ottawa, Ontario, Canada
Abstract
Abstract
Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a leading cause of maternal mortality during pregnancy. DVT and PE are commonly suspected due to many mimicking signs and symptoms that are normal in pregnancy. However, validated diagnostic approaches are lacking, and a fear of teratogenic/oncogenic exposure from imaging procedures affects the acceptability of diagnostic approaches used for VTE during pregnancy. DVT and PE treatment in pregnancy is also challenging due to this lack of validated diagnostic approaches, changes in maternal physiology, and the need for intact hemostasis at the time of delivery/epidural analgesia. Prevention requires an optimal balancing of absolute increased bleeding risk from pharmacologic thromboprophylaxis and the absolute benefit of reduced DVT and PE, which, while serious, are relatively uncommon.
Publisher
American Society of Hematology
Reference63 articles.
1. Maternal mortality in the United States, 1979–1986;Atrash;Obstet Gynecol,1990
2. The Confidential Enquiry into Maternal and Child Health (CEMACH),2007
3. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database;Simpson;BJOG,2001
4. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study;Heit;Ann Intern Med,2005
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献